PlainRecalls
FDA Drug Moderate Class II Terminated

glycopyrrolate 1 mg/5 mL (0.2 mg/mL), For Anesthesia Use, Syringe, RX ONLY, CAPS, Inc., 2200 South 43rd Avenue, Phoenix, AZ 85043, NDC: 72196-6084-1

Reported: August 9, 2023 Initiated: July 14, 2023 #D-0952-2023

Product Description

glycopyrrolate 1 mg/5 mL (0.2 mg/mL), For Anesthesia Use, Syringe, RX ONLY, CAPS, Inc., 2200 South 43rd Avenue, Phoenix, AZ 85043, NDC: 72196-6084-1

Reason for Recall

Lack of assurance of sterility. Validation data for decontamination cycles is lacking.

Details

Units Affected
770 Syringes
Distribution
Nationwide in the USA
Location
Phoenix, AZ

Frequently Asked Questions

What product was recalled?
glycopyrrolate 1 mg/5 mL (0.2 mg/mL), For Anesthesia Use, Syringe, RX ONLY, CAPS, Inc., 2200 South 43rd Avenue, Phoenix, AZ 85043, NDC: 72196-6084-1. Recalled by Central Admixture Pharmacy Services, Inc.. Units affected: 770 Syringes.
Why was this product recalled?
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Which agency issued this recall?
This recall was issued by the FDA Drug on August 9, 2023. Severity: Moderate. Recall number: D-0952-2023.